VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q60638965 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241121000106.0
008 241121nneanz||abbn n and d
035 ‎‡a (WKP)Q60638965‏
024 ‎‡a 0000-0002-3870-2804‏ ‎‡2 orcid‏
024 ‎‡a 7404152938‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q60638965‏
100 0 ‎‡a Charles L White‏ ‎‡9 es‏ ‎‡9 ast‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a চার্লস এল হোয়াইট‏ ‎‡9 bn‏
400 0 ‎‡a Charles L White‏ ‎‡c researcher ORCID ID = 0000-0002-3870-2804‏ ‎‡9 en‏
400 0 ‎‡a Charles L White‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's A Distinct Class of Antibodies May Be an Indicator of Gray Matter Autoimmunity in Early and Established Relapsing Remitting Multiple Sclerosis Patients.‏
670 ‎‡a Author's A neurodegenerative disease landscape of rare mutations in Colombia due to founder effects‏
670 ‎‡a Author's A rapid one-step extraction procedure for the isolation of ubiquitin from human erythrocytes for antibody production.‏
670 ‎‡a Author's Abnormal neurites containing C-terminally truncated alpha-synuclein are present in Alzheimer's disease without conventional Lewy body pathology.‏
670 ‎‡a Author's Absence of expression of SMARCB1/INI1 in malignant rhabdoid tumors of the central nervous system, kidneys and soft tissue: an immunohistochemical study with implications for diagnosis.‏
670 ‎‡a Author's Abstract P18. Correlation between Facial Nerve Axonal Load and Age and its Relevance to Facial Reanimation.‏
670 ‎‡a Author's Adult Brainstem Gliomas With H3K27M Mutation: Radiology, Pathology, and Prognosis.‏
670 ‎‡a Author's Adult polyglucosan body disease with GBE1 haploinsufficiency and concomitant frontotemporal lobar degeneration‏
670 ‎‡a Author's Aggressive Behavior in Silent Subtype III Pituitary Adenomas May Depend on Suppression of Local Immune Response: A Whole Transcriptome Analysis‏
670 ‎‡a Author's Aggressive FUS-Mutant Motor Neuron Disease Without Profound Spinal Cord Pathology‏
670 ‎‡a Author's Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy‏
670 ‎‡a Author's Alpha-synuclein expression in the developing human brain‏
670 ‎‡a Author's Altered expression levels of the protein phosphatase 2A ABalphaC enzyme are associated with Alzheimer disease pathology.‏
670 ‎‡a Author's Alzheimer disease paired helical filament core structures contain glycolipid.‏
670 ‎‡a Author's Alzheimer disease: what changes in the brain cause dementia?‏
670 ‎‡a Author's Alzheimer's disease: neurofibrillary tangles in nuclei that project to the cerebral cortex.‏
670 ‎‡a Author's Antemortem detection of Parkinson's disease pathology in peripheral biopsies using artificial intelligence‏
670 ‎‡a Author's Artificial intelligence in neuropathology: deep learning-based assessment of tauopathy‏
670 ‎‡a Author's Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers‏
670 ‎‡a Author's Ataxin-2 repeat-length variation and neurodegeneration‏
670 ‎‡a Author's Atypical multiple system atrophy is a new subtype of frontotemporal lobar degeneration: frontotemporal lobar degeneration associated with α-synuclein.‏
670 ‎‡a Author's Atypical teratoid/rhabdoid tumor: cytology and differential diagnosis in adults‏
670 ‎‡a Author's Beta-amyloid precursor protein immunohistochemistry in the evaluation of pediatric traumatic optic nerve injury‏
670 ‎‡a Author's Beta-amyloid precursor protein staining in nonhomicidal pediatric medicolegal autopsies‏
670 ‎‡a Author's Beta-amyloid precursor protein staining of nonaccidental central nervous system injury in pediatric autopsies.‏
670 ‎‡a Author's C9orf72 intermediate repeats are associated with corticobasal degeneration, increased C9orf72 expression and disruption of autophagy‏
670 ‎‡a Author's C9ORF72 repeat expansions in cases with previously identified pathogenic mutations‏
670 ‎‡a Author's Can alzheimer's disease and dementias with Lewy bodies be distinguished clinically?‏
670 ‎‡a Author's Chromosome 22q deletions in atypical teratoid/rhabdoid tumors in adults‏
670 ‎‡a Author's Clinical and neuropsychological profile of patients with dementia and chronic traumatic encephalopathy‏
670 ‎‡a Author's Clinical criteria for the diagnosis of Alzheimer disease: still good after all these years.‏
670 ‎‡a Author's Clinical Outcome of Silent Subtype III Pituitary Adenomas Diagnosed by Immunohistochemistry.‏
670 ‎‡a Author's Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions‏
670 ‎‡a Author's Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodies‏
670 ‎‡a Author's Constitutive and regulated expression of the mouse Dinb‏
670 ‎‡a Author's Constitutive and regulated expression of the mouse Dinb (Polkappa) gene encoding DNA polymerase kappa.‏
670 ‎‡a Author's Correlation between Facial Nerve Axonal Load and Age and Its Relevance to Facial Reanimation‏
670 ‎‡a Author's Cortical synapse loss in progressive supranuclear palsy.‏
670 ‎‡a Author's Crohn's disease and ulcerative colitis in the same patient‏
670 ‎‡a Author's Cytology of subependymoma.‏
670 ‎‡a Author's Diffuse microvascular C5b-9 deposition is a common feature in muscle and nerve biopsies from diabetic patients‏
670 ‎‡a Author's Disease-specific patterns of locus coeruleus cell loss‏
670 ‎‡a Author's Distinct Expression Patterns of Carbonic Anhydrase IX in Clear Cell, Microcystic, and Angiomatous Meningiomas‏
670 ‎‡a Author's Does past or present depression differentiate Lewy body from Alzheimer disease?‏
670 ‎‡a Author's Downregulation of protein phosphatase 2A carboxyl methylation and methyltransferase may contribute to Alzheimer disease pathogenesis.‏
670 ‎‡a Author's Early morphologic diagnosis of herpes simplex virus encephalitis: Advantages of electron microscopy and immunoperoxidase staining‏
670 ‎‡a Author's Early Selective Vulnerability of the CA2 Hippocampal Subfield in Primary Age-Related Tauopathy‏
670 ‎‡a Author's Evaluation of alpha-synuclein immunohistochemical methods used by invited experts‏
670 ‎‡a Author's Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases‏
670 ‎‡a Author's Expression of MAP 2 by haemangioblastomas: an immunohistochemical study with implications for diagnosis‏
670 ‎‡a Author's Facial Nerve Axonal Analysis and Anatomical Localization in Donor Nerve: Optimizing Axonal Load for Cross-Facial Nerve Grafting in Facial Reanimation‏
670 ‎‡a Author's Factor VIII related antigen and glial fibrillary acidic protein immunoreactivity in the differential diagnosis of central nervous system hemangioblastomas‏
670 ‎‡a Author's Frequency of unilateral and bilateral mesial temporal sclerosis in primary and secondary epilepsy: a forensic autopsy study.‏
670 ‎‡a Author's Frontal lobe dementia with novel tauopathy: sporadic multiple system tauopathy with dementia.‏
670 ‎‡a Author's Frontotemporal and motor neurone degeneration with neurofilament inclusion bodies: additional evidence for overlap between FTD and ALS.‏
670 ‎‡a Author's Frontotemporal lobar degeneration with motor neuron disease-type inclusions predominates in 76 cases of frontotemporal degeneration.‏
670 ‎‡a Author's FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration‏
670 ‎‡a Author's Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration‏
670 ‎‡a Author's Genetic modifiers in carriers of repeat expansions in the C9ORF72 gene‏
670 ‎‡a Author's Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD‏
670 ‎‡a Author's Genome-Wide Analysis of Glioblastoma Patients with Unexpectedly Long Survival‏
670 ‎‡a Author's Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy‏
670 ‎‡a Author's Globular glial tauopathies‏
670 ‎‡a Author's Globular glial tauopathies (GGT): consensus recommendations‏
670 ‎‡a Author's High expression of the stem cell marker nestin is an adverse prognostic factor in WHO grade II-III astrocytomas and oligoastrocytomas‏
670 ‎‡a Author's Hippocampal sclerosis in dementia, epilepsy, and ischemic injury: differential vulnerability of hippocampal subfields‏
670 ‎‡a Author's Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study‏
670 ‎‡a Author's Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4)‏
670 ‎‡a Author's Improved rabbit brain tumor model amenable to diagnostic radiographic procedures.‏
670 ‎‡a Author's In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease‏
670 ‎‡a Author's Interphase Cytogenetic (In Situ Hybridization) Analysis of Astrocytomas Using Archival, Formalin-Fixed, Paraffin-Embedded Tissue and Nonfluorescent Light Microscopy‏
670 ‎‡a Author's Lateralization on Neuroimaging Does Not Differentiate Frontotemporal Lobar Degeneration from Alzheimer’s Disease‏
670 ‎‡a Author's Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotype‏
670 ‎‡a Author's Lipidomic and Transcriptomic Basis of Lysosomal Dysfunction in Progranulin Deficiency.‏
670 ‎‡a Author's Microfibrillar collagen model of canine cerebral infarction‏
670 ‎‡a Author's Molecular characterization of novel progranulin‏
670 ‎‡a Author's Molecular characterization of novel progranulin (GRN) mutations in frontotemporal dementia‏
670 ‎‡a Author's Morin Stain Detects Aluminum-Containing Macrophages in Macrophagic Myofasciitis and Vaccination Granuloma With High Sensitivity and Specificity.‏
670 ‎‡a Author's MRI evaluation of amyloid myopathy‏
670 ‎‡a Author's Multisite Assessment of Aging-Related Tau Astrogliopathy (ARTAG).‏
670 ‎‡a Author's Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration‏
670 ‎‡a Author's Neuroanatomic profile of polyglutamine immunoreactivity in Huntington disease brains.‏
670 ‎‡a Author's Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration‏
670 ‎‡a Author's NHERF1/EBP50 controls morphogenesis of 3D colonic glands by stabilizing PTEN and ezrin-radixin-moesin proteins at the apical membrane‏
670 ‎‡a Author's NHERF1/EBP50 is an organizer of polarity structures and a diagnostic marker in ependymoma‏
670 ‎‡a Author's Nonbacterial thrombotic endocarditis in bone marrow transplant patients.‏
670 ‎‡a Author's Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders‏
670 ‎‡a Author's Pediatric oligodendrogliomas: a study of molecular alterations on 1p and 19q using fluorescence in situ hybridization.‏
670 ‎‡a Author's Percutaneous translumbar spinal cord compression injury in a dog model that uses angioplasty balloons: MR imaging and histopathologic findings.‏
670 ‎‡a Author's Percutaneous translumbar spinal cord compression injury in dogs from an angioplasty balloon: MR and histopathologic changes with balloon sizes and compression times‏
670 ‎‡a Author's Peripheral VH4+ plasmablasts demonstrate autoreactive B cell expansion toward brain antigens in early multiple sclerosis patients‏
670 ‎‡a Author's PHLPP2 suppresses the NF-κB pathway by inactivating IKKβ kinase‏
670 ‎‡a Author's Phosphorylation of the tubulin-binding protein, stathmin, by Cdk5 and MAP kinases in the brain.‏
670 ‎‡a Author's Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study.‏
670 ‎‡a Author's Predictors of cognitive impairment in primary age-related tauopathy: an autopsy study‏
670 ‎‡a Author's Primary age-related tauopathy‏
670 ‎‡a Author's Primary age-related tauopathy (PART): a common pathology associated with human aging‏
670 ‎‡a Author's Prognostic value of proliferation index and expression of the RNA component of human telomerase‏
670 ‎‡a Author's Prognostic value of proliferation index and expression of the RNA component of human telomerase (hTR) in papillary meningiomas‏
670 ‎‡a Author's Progressive supranuclear palsy with dementia: cortical pathology.‏
670 ‎‡a Author's Proliferative activity in craniopharyngiomas: clinicopathological correlations in adults and children.‏
670 ‎‡a Author's Protein phosphatase 2A associates with and regulates atypical PKC and the epithelial tight junction complex‏
670 ‎‡a Author's Reduced synaptic STIM2 expression and impaired store-operated calcium entry cause destabilization of mature spines in mutant presenilin mice‏
670 ‎‡a Author's Regional changes of cortical mean diffusivities with aging after correction of partial volume effects‏
670 ‎‡a Author's Reply: LATE to the PART-y‏
670 ‎‡a Author's Response to Parkinnen et al. and Jellinger‏
670 ‎‡a Author's Reversible middle cerebral artery embolization in dogs without intracranial surgery.‏
670 ‎‡a Author's Risk factors for earlier dementia onset in autopsy-confirmed Alzheimer's disease, mixed Alzheimer's with Lewy bodies, and pure Lewy body disease‏
670 ‎‡a Author's Spinocerebellar Ataxia Type 3: A Case Report and Literature Review‏
670 ‎‡a Author's Synapse loss may be a minor contributor to decreased regional cerebral blood flow in Alzheimer disease.‏
670 ‎‡a Author's TAR DNA-binding protein 43 immunohistochemistry reveals extensive neuritic pathology in FTLD-U: a midwest-southwest consortium for FTLD study‏
670 ‎‡a Author's TC-99m HMPAO Brain Blood Flow Imaging in the Dementias with Histopathologic Correlation in 73 Patients‏
670 ‎‡a Author's Tc-99m HMPAO SPECT in the differential diagnosis of the dementias with histopathologic confirmation.‏
670 ‎‡a Author's TDP-43 A315T mutation in familial motor neuron disease‏
670 ‎‡a Author's TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions‏
670 ‎‡a Author's TDP-43 pathology in primary progressive aphasia and frontotemporal dementia with pathologic Alzheimer disease‏
670 ‎‡a Author's The protein phosphatase PP2A/Bα binds to the microtubule-associated proteins Tau and MAP2 at a motif also recognized by the kinase Fyn: implications for tauopathies.‏
670 ‎‡a Author's The role of cortical connectivity in Alzheimer's disease pathogenesis: a review and model system.‏
670 ‎‡a Author's TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions‏
670 ‎‡a Author's TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia‏
670 ‎‡a Author's TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers.‏
670 ‎‡a Author's Traumatic Brain Injury History Is Associated With an Earlier Age of Dementia Onset in Autopsy-Confirmed Alzheimer's Disease‏
670 ‎‡a Author's TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease‏
670 ‎‡a Author's Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction‏
670 ‎‡a Author's Widespread tau seeding activity at early Braak stages.‏
909 ‎‡a (orcid) 0000000238702804‏ ‎‡9 1‏
909 ‎‡a (scopus) 7404152938‏ ‎‡9 1‏
912 ‎‡a agingrelatedtauastrogliopathyartagharmonizedevaluationstrategy‏ ‎‡A Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy‏ ‎‡9 1‏
912 ‎‡a commonvariantsat7p21areassociatedwithfrontotemporallobardegenerationwithtdp43inclusions‏ ‎‡A Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions‏ ‎‡9 1‏
912 ‎‡a evidenceforaroleoftherarepa152tvariantinmaptinincreasingtheriskforftdspectrumandalzheimersdiseases‏ ‎‡A Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases‏ ‎‡9 1‏
912 ‎‡a genomewideanalysesaspartoftheinternationalftldtdpwholegenomesequencingconsortiumrevealsnoveldiseaseriskfactorsandincreasessupportforimmunedysfunctioninftld‏ ‎‡A Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD‏ ‎‡9 1‏
912 ‎‡a potentialgeneticmodifiersofdiseaseriskandageatonsetinpatientswithfrontotemporallobardegenerationandgrnmutationsagenomewideassociationstudy‏ ‎‡A Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study.‏ ‎‡9 1‏
912 ‎‡a tmem106bisageneticmodifieroffrontotemporallobardegenerationwithc9orf72hexanucleotiderepeatexpansions‏ ‎‡A TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions‏ ‎‡9 1‏
919 ‎‡a tmem106bregulatesprogranulinlevelsandthepenetranceofftldingrnmutationcarriers‏ ‎‡A TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers.‏ ‎‡9 1‏
919 ‎‡a traumaticbraininjuryhistoryisassociatedwithanearlierageofdementiaonsetinautopsyconfirmedalzheimersdisease‏ ‎‡A Traumatic Brain Injury History Is Associated With an Earlier Age of Dementia Onset in Autopsy-Confirmed Alzheimer's Disease‏ ‎‡9 1‏
919 ‎‡a trem2inneurodegenerationevidenceforassociationofthepr47hvariantwithfrontotemporaldementiaandparkinsonsdisease‏ ‎‡A TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease‏ ‎‡9 1‏
919 ‎‡a unifiedstagingsystemforlewybodydisorderscorrelationwithnigrostriataldegenerationcognitiveimpairmentandmotordysfunction‏ ‎‡A Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction‏ ‎‡9 1‏
919 ‎‡a widespreadtauseedingactivityatearlybraakstages‏ ‎‡A Widespread tau seeding activity at early Braak stages.‏ ‎‡9 1‏
919 ‎‡a distinctclassofantibodiesmaybeanindicatorofgraymatterautoimmunityinearlyandestablishedrelapsingremittingmultiplesclerosispatients‏ ‎‡A A Distinct Class of Antibodies May Be an Indicator of Gray Matter Autoimmunity in Early and Established Relapsing Remitting Multiple Sclerosis Patients.‏ ‎‡9 1‏
919 ‎‡a neurodegenerativediseaselandscapeofraremutationsincolombiaduetofoundereffects‏ ‎‡A A neurodegenerative disease landscape of rare mutations in Colombia due to founder effects‏ ‎‡9 1‏
919 ‎‡a rapid1stepextractionprocedurefortheisolationofubiquitinfromhumanerythrocytesforantibodyproduction‏ ‎‡A A rapid one-step extraction procedure for the isolation of ubiquitin from human erythrocytes for antibody production.‏ ‎‡9 1‏
919 ‎‡a abnormalneuritescontaining100terminallytruncatedalphasynucleinarepresentinalzheimersdiseasewithoutconventionallewybodypathology‏ ‎‡A Abnormal neurites containing C-terminally truncated alpha-synuclein are present in Alzheimer's disease without conventional Lewy body pathology.‏ ‎‡9 1‏
919 ‎‡a absenceofexpressionofsmarcb1ini1inmalignantrhabdoidtumorsofthecentralnervoussystemkidneysandsofttissueanimmunohistochemicalstudywithimplicationsfordiagnosis‏ ‎‡A Absence of expression of SMARCB1/INI1 in malignant rhabdoid tumors of the central nervous system, kidneys and soft tissue: an immunohistochemical study with implications for diagnosis.‏ ‎‡9 1‏
919 ‎‡a abstractp18correlationbetweenfacialnerveaxonalloadandageanditsrelevancetofacialreanimation‏ ‎‡A Abstract P18. Correlation between Facial Nerve Axonal Load and Age and its Relevance to Facial Reanimation.‏ ‎‡9 1‏
919 ‎‡a adultbrainstemgliomaswithh3k27mmutationradiologypathologyandprognosis‏ ‎‡A Adult Brainstem Gliomas With H3K27M Mutation: Radiology, Pathology, and Prognosis.‏ ‎‡9 1‏
919 ‎‡a adultpolyglucosanbodydiseasewithgbe1haploinsufficiencyandconcomitantfrontotemporallobardegeneration‏ ‎‡A Adult polyglucosan body disease with GBE1 haploinsufficiency and concomitant frontotemporal lobar degeneration‏ ‎‡9 1‏
919 ‎‡a aggressivebehaviorinsilentsubtype3pituitaryadenomasmaydependonsuppressionoflocalimmuneresponseawholetranscriptomeanalysis‏ ‎‡A Aggressive Behavior in Silent Subtype III Pituitary Adenomas May Depend on Suppression of Local Immune Response: A Whole Transcriptome Analysis‏ ‎‡9 1‏
919 ‎‡a aggressivefusmutantmotorneurondiseasewithoutprofoundspinalcordpathology‏ ‎‡A Aggressive FUS-Mutant Motor Neuron Disease Without Profound Spinal Cord Pathology‏ ‎‡9 1‏
919 ‎‡a alphasynucleinexpressioninthedevelopinghumanbrain‏ ‎‡A Alpha-synuclein expression in the developing human brain‏ ‎‡9 1‏
919 ‎‡a alteredexpressionlevelsoftheproteinphosphatase2aabalphacenzymeareassociatedwithalzheimerdiseasepathology‏ ‎‡A Altered expression levels of the protein phosphatase 2A ABalphaC enzyme are associated with Alzheimer disease pathology.‏ ‎‡9 1‏
919 ‎‡a alzheimerdiseasepairedhelicalfilamentcorestructurescontainglycolipid‏ ‎‡A Alzheimer disease paired helical filament core structures contain glycolipid.‏ ‎‡9 1‏
919 ‎‡a alzheimerdiseasewhatchangesinthebraincausedementia‏ ‎‡A Alzheimer disease: what changes in the brain cause dementia?‏ ‎‡9 1‏
919 ‎‡a alzheimersdiseaseneurofibrillarytanglesinnucleithatprojecttothecerebralcortex‏ ‎‡A Alzheimer's disease: neurofibrillary tangles in nuclei that project to the cerebral cortex.‏ ‎‡9 1‏
919 ‎‡a antemortemdetectionofparkinsonsdiseasepathologyinperipheralbiopsiesusingartificialintelligence‏ ‎‡A Antemortem detection of Parkinson's disease pathology in peripheral biopsies using artificial intelligence‏ ‎‡9 1‏
919 ‎‡a artificialintelligenceinneuropathologydeeplearningbasedassessmentoftauopathy‏ ‎‡A Artificial intelligence in neuropathology: deep learning-based assessment of tauopathy‏ ‎‡9 1‏
919 ‎‡a ataxin2aspotentialdiseasemodifierinc9orf72expansioncarriers‏ ‎‡A Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers‏ ‎‡9 1‏
919 ‎‡a ataxin2repeatlengthvariationandneurodegeneration‏ ‎‡A Ataxin-2 repeat-length variation and neurodegeneration‏ ‎‡9 1‏
919 ‎‡a atypicalmultiplesystematrophyisanewsubtypeoffrontotemporallobardegenerationfrontotemporallobardegenerationassociatedwithαsynuclein‏ ‎‡A Atypical multiple system atrophy is a new subtype of frontotemporal lobar degeneration: frontotemporal lobar degeneration associated with α-synuclein.‏ ‎‡9 1‏
919 ‎‡a atypicalteratoidrhabdoidtumorcytologyanddifferentialdiagnosisinadults‏ ‎‡A Atypical teratoid/rhabdoid tumor: cytology and differential diagnosis in adults‏ ‎‡9 1‏
919 ‎‡a betaamyloidprecursorproteinimmunohistochemistryintheevaluationofpediatrictraumaticopticnerveinjury‏ ‎‡A Beta-amyloid precursor protein immunohistochemistry in the evaluation of pediatric traumatic optic nerve injury‏ ‎‡9 1‏
919 ‎‡a betaamyloidprecursorproteinstaininginnonhomicidalpediatricmedicolegalautopsies‏ ‎‡A Beta-amyloid precursor protein staining in nonhomicidal pediatric medicolegal autopsies‏ ‎‡9 1‏
919 ‎‡a betaamyloidprecursorproteinstainingofnonaccidentalcentralnervoussysteminjuryinpediatricautopsies‏ ‎‡A Beta-amyloid precursor protein staining of nonaccidental central nervous system injury in pediatric autopsies.‏ ‎‡9 1‏
919 ‎‡a c9orf72intermediaterepeatsareassociatedwithcorticobasaldegenerationincreasedc9orf72expressionanddisruptionofautophagy‏ ‎‡A C9orf72 intermediate repeats are associated with corticobasal degeneration, increased C9orf72 expression and disruption of autophagy‏ ‎‡9 1‏
919 ‎‡a c9orf72repeatexpansionsincaseswithpreviouslyidentifiedpathogenicmutations‏ ‎‡A C9ORF72 repeat expansions in cases with previously identified pathogenic mutations‏ ‎‡9 1‏
919 ‎‡a canalzheimersdiseaseanddementiaswithlewybodiesbedistinguishedclinically‏ ‎‡A Can alzheimer's disease and dementias with Lewy bodies be distinguished clinically?‏ ‎‡9 1‏
919 ‎‡a chromosome22qdeletionsinatypicalteratoidrhabdoidtumorsinadults‏ ‎‡A Chromosome 22q deletions in atypical teratoid/rhabdoid tumors in adults‏ ‎‡9 1‏
919 ‎‡a clinicalandneuropsychologicalprofileofpatientswithdementiaandchronictraumaticencephalopathy‏ ‎‡A Clinical and neuropsychological profile of patients with dementia and chronic traumatic encephalopathy‏ ‎‡9 1‏
919 ‎‡a clinicalcriteriaforthediagnosisofalzheimerdiseasestillgoodafteralltheseyears‏ ‎‡A Clinical criteria for the diagnosis of Alzheimer disease: still good after all these years.‏ ‎‡9 1‏
919 ‎‡a clinicaloutcomeofsilentsubtype3pituitaryadenomasdiagnosedbyimmunohistochemistry‏ ‎‡A Clinical Outcome of Silent Subtype III Pituitary Adenomas Diagnosed by Immunohistochemistry.‏ ‎‡9 1‏
919 ‎‡a comprehensivecharacterizationandoptimizationofantilrrk2leucinerichrepeatkinase2monoclonalantibodies‏ ‎‡A Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodies‏ ‎‡9 1‏
919 ‎‡a constitutiveandregulatedexpressionofthemousedinb‏ ‎‡A Constitutive and regulated expression of the mouse Dinb‏ ‎‡9 1‏
919 ‎‡a constitutiveandregulatedexpressionofthemousedinbpolkappageneencodingdnapolymerasekappa‏ ‎‡A Constitutive and regulated expression of the mouse Dinb (Polkappa) gene encoding DNA polymerase kappa.‏ ‎‡9 1‏
919 ‎‡a correlationbetweenfacialnerveaxonalloadandageanditsrelevancetofacialreanimation‏ ‎‡A Correlation between Facial Nerve Axonal Load and Age and Its Relevance to Facial Reanimation‏ ‎‡9 1‏
919 ‎‡a corticalsynapselossinprogressivesupranuclearpalsy‏ ‎‡A Cortical synapse loss in progressive supranuclear palsy.‏ ‎‡9 1‏
919 ‎‡a crohnsdiseaseandulcerativecolitisinthesamepatient‏ ‎‡A Crohn's disease and ulcerative colitis in the same patient‏ ‎‡9 1‏
919 ‎‡a cytologyofsubependymoma‏ ‎‡A Cytology of subependymoma.‏ ‎‡9 1‏
919 ‎‡a diffusemicrovascularc5b9depositionisacommonfeatureinmuscleandnervebiopsiesfromdiabeticpatients‏ ‎‡A Diffuse microvascular C5b-9 deposition is a common feature in muscle and nerve biopsies from diabetic patients‏ ‎‡9 1‏
919 ‎‡a diseasespecificpatternsoflocuscoeruleuscellloss‏ ‎‡A Disease-specific patterns of locus coeruleus cell loss‏ ‎‡9 1‏
919 ‎‡a distinctexpressionpatternsofcarbonicanhydrase9inclearcellmicrocysticandangiomatousmeningiomas‏ ‎‡A Distinct Expression Patterns of Carbonic Anhydrase IX in Clear Cell, Microcystic, and Angiomatous Meningiomas‏ ‎‡9 1‏
919 ‎‡a doespastorpresentdepressiondifferentiatelewybodyfromalzheimerdisease‏ ‎‡A Does past or present depression differentiate Lewy body from Alzheimer disease?‏ ‎‡9 1‏
919 ‎‡a downregulationofproteinphosphatase2acarboxylmethylationandmethyltransferasemaycontributetoalzheimerdiseasepathogenesis‏ ‎‡A Downregulation of protein phosphatase 2A carboxyl methylation and methyltransferase may contribute to Alzheimer disease pathogenesis.‏ ‎‡9 1‏
919 ‎‡a earlymorphologicdiagnosisofherpessimplexvirusencephalitisadvantagesofelectronmicroscopyandimmunoperoxidasestaining‏ ‎‡A Early morphologic diagnosis of herpes simplex virus encephalitis: Advantages of electron microscopy and immunoperoxidase staining‏ ‎‡9 1‏
919 ‎‡a earlyselectivevulnerabilityoftheca2hippocampalsubfieldinprimaryagerelatedtauopathy‏ ‎‡A Early Selective Vulnerability of the CA2 Hippocampal Subfield in Primary Age-Related Tauopathy‏ ‎‡9 1‏
919 ‎‡a evaluationofalphasynucleinimmunohistochemicalmethodsusedbyinvitedexperts‏ ‎‡A Evaluation of alpha-synuclein immunohistochemical methods used by invited experts‏ ‎‡9 1‏
919 ‎‡a expressionofmap2byhaemangioblastomasanimmunohistochemicalstudywithimplicationsfordiagnosis‏ ‎‡A Expression of MAP 2 by haemangioblastomas: an immunohistochemical study with implications for diagnosis‏ ‎‡9 1‏
919 ‎‡a facialnerveaxonalanalysisandanatomicallocalizationindonornerveoptimizingaxonalloadforcrossfacialnervegraftinginfacialreanimation‏ ‎‡A Facial Nerve Axonal Analysis and Anatomical Localization in Donor Nerve: Optimizing Axonal Load for Cross-Facial Nerve Grafting in Facial Reanimation‏ ‎‡9 1‏
919 ‎‡a factor8relatedantigenandglialfibrillaryacidicproteinimmunoreactivityinthedifferentialdiagnosisofcentralnervoussystemhemangioblastomas‏ ‎‡A Factor VIII related antigen and glial fibrillary acidic protein immunoreactivity in the differential diagnosis of central nervous system hemangioblastomas‏ ‎‡9 1‏
919 ‎‡a frequencyofunilateralandbilateralmesialtemporalsclerosisinprimaryandsecondaryepilepsyaforensicautopsystudy‏ ‎‡A Frequency of unilateral and bilateral mesial temporal sclerosis in primary and secondary epilepsy: a forensic autopsy study.‏ ‎‡9 1‏
919 ‎‡a frontallobedementiawithnoveltauopathysporadicmultiplesystemtauopathywithdementia‏ ‎‡A Frontal lobe dementia with novel tauopathy: sporadic multiple system tauopathy with dementia.‏ ‎‡9 1‏
919 ‎‡a frontotemporalandmotorneuronedegenerationwithneurofilamentinclusionbodiesadditionalevidenceforoverlapbetweenftdandals‏ ‎‡A Frontotemporal and motor neurone degeneration with neurofilament inclusion bodies: additional evidence for overlap between FTD and ALS.‏ ‎‡9 1‏
919 ‎‡a frontotemporallobardegenerationwithmotorneurondiseasetypeinclusionspredominatesin76casesoffrontotemporaldegeneration‏ ‎‡A Frontotemporal lobar degeneration with motor neuron disease-type inclusions predominates in 76 cases of frontotemporal degeneration.‏ ‎‡9 1‏
919 ‎‡a fuspathologydefinesthemajorityoftauandtdp43negativefrontotemporallobardegeneration‏ ‎‡A FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration‏ ‎‡9 1‏
919 ‎‡a geneticandclinicalfeaturesofprogranulinassociatedfrontotemporallobardegeneration‏ ‎‡A Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration‏ ‎‡9 1‏
919 ‎‡a geneticmodifiersincarriersofrepeatexpansionsinthec9orf72gene‏ ‎‡A Genetic modifiers in carriers of repeat expansions in the C9ORF72 gene‏ ‎‡9 1‏
919 ‎‡a genomewideanalysisofglioblastomapatientswithunexpectedlylongsurvival‏ ‎‡A Genome-Wide Analysis of Glioblastoma Patients with Unexpectedly Long Survival‏ ‎‡9 1‏
919 ‎‡a genomewideassociationstudyofcorticobasaldegenerationidentifiesriskvariantssharedwithprogressivesupranuclearpalsy‏ ‎‡A Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy‏ ‎‡9 1‏
919 ‎‡a globularglialtauopathies‏ ‎‡A Globular glial tauopathies‏ ‎‡9 1‏
919 ‎‡a globularglialtauopathiesggtconsensusrecommendations‏ ‎‡A Globular glial tauopathies (GGT): consensus recommendations‏ ‎‡9 1‏
919 ‎‡a highexpressionofthestemcellmarkernestinisanadverseprognosticfactorinwhograde23astrocytomasandoligoastrocytomas‏ ‎‡A High expression of the stem cell marker nestin is an adverse prognostic factor in WHO grade II-III astrocytomas and oligoastrocytomas‏ ‎‡9 1‏
919 ‎‡a hippocampalsclerosisindementiaepilepsyandischemicinjurydifferentialvulnerabilityofhippocampalsubfields‏ ‎‡A Hippocampal sclerosis in dementia, epilepsy, and ischemic injury: differential vulnerability of hippocampal subfields‏ ‎‡9 1‏
919 ‎‡a immunohistochemicalmethodandhistopathologyjudgingforthesystemicsynucleinsamplingstudy‏ ‎‡A Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study‏ ‎‡9 1‏
919 ‎‡a immunohistochemicalmethodandhistopathologyjudgingforthesystemicsynucleinsamplingstudys4‏ ‎‡A Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4)‏ ‎‡9 1‏
919 ‎‡a improvedrabbitbraintumormodelamenabletodiagnosticradiographicprocedures‏ ‎‡A Improved rabbit brain tumor model amenable to diagnostic radiographic procedures.‏ ‎‡9 1‏
919 ‎‡a invivodistributionofαsynucleininmultipletissuesandbiofluidsinparkinsondisease‏ ‎‡A In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease‏ ‎‡9 1‏
919 ‎‡a interphasecytogeneticinsituhybridizationanalysisofastrocytomasusingarchivalformalinfixedparaffinembeddedtissueandnonfluorescentlightmicroscopy‏ ‎‡A Interphase Cytogenetic (In Situ Hybridization) Analysis of Astrocytomas Using Archival, Formalin-Fixed, Paraffin-Embedded Tissue and Nonfluorescent Light Microscopy‏ ‎‡9 1‏
919 ‎‡a lateralizationonneuroimagingdoesnotdifferentiatefrontotemporallobardegenerationfromalzheimersdisease‏ ‎‡A Lateralization on Neuroimaging Does Not Differentiate Frontotemporal Lobar Degeneration from Alzheimer’s Disease‏ ‎‡9 1‏
919 ‎‡a lengthofnormalallelesofc9orf72ggggccrepeatdonotinfluencediseasephenotype‏ ‎‡A Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotype‏ ‎‡9 1‏
919 ‎‡a lipidomicandtranscriptomicbasisoflysosomaldysfunctioninprogranulindeficiency‏ ‎‡A Lipidomic and Transcriptomic Basis of Lysosomal Dysfunction in Progranulin Deficiency.‏ ‎‡9 1‏
919 ‎‡a microfibrillarcollagenmodelofcaninecerebralinfarction‏ ‎‡A Microfibrillar collagen model of canine cerebral infarction‏ ‎‡9 1‏
919 ‎‡a molecularcharacterizationofnovelprogranulin‏ ‎‡A Molecular characterization of novel progranulin‏ ‎‡9 1‏
919 ‎‡a molecularcharacterizationofnovelprogranulingrnmutationsinfrontotemporaldementia‏ ‎‡A Molecular characterization of novel progranulin (GRN) mutations in frontotemporal dementia‏ ‎‡9 1‏
919 ‎‡a morinstaindetectsaluminumcontainingmacrophagesinmacrophagicmyofasciitisandvaccinationgranulomawithhighsensitivityandspecificity‏ ‎‡A Morin Stain Detects Aluminum-Containing Macrophages in Macrophagic Myofasciitis and Vaccination Granuloma With High Sensitivity and Specificity.‏ ‎‡9 1‏
919 ‎‡a mrievaluationofamyloidmyopathy‏ ‎‡A MRI evaluation of amyloid myopathy‏ ‎‡9 1‏
919 ‎‡a multisiteassessmentofagingrelatedtauastrogliopathyartag‏ ‎‡A Multisite Assessment of Aging-Related Tau Astrogliopathy (ARTAG).‏ ‎‡9 1‏
919 ‎‡a mutationsinprogranulinareamajorcauseofubiquitinpositivefrontotemporallobardegeneration‏ ‎‡A Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration‏ ‎‡9 1‏
919 ‎‡a neuroanatomicprofileofpolyglutamineimmunoreactivityinhuntingtondiseasebrains‏ ‎‡A Neuroanatomic profile of polyglutamine immunoreactivity in Huntington disease brains.‏ ‎‡9 1‏
919 ‎‡a neuropathologicdiagnosticandnosologiccriteriaforfrontotemporallobardegenerationconsensusoftheconsortiumforfrontotemporallobardegeneration‏ ‎‡A Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration‏ ‎‡9 1‏
919 ‎‡a nherf1ebp50controlsmorphogenesisof3dcolonicglandsbystabilizingptenandezrinradixinmoesinproteinsattheapicalmembrane‏ ‎‡A NHERF1/EBP50 controls morphogenesis of 3D colonic glands by stabilizing PTEN and ezrin-radixin-moesin proteins at the apical membrane‏ ‎‡9 1‏
919 ‎‡a nherf1ebp50isanorganizerofpolaritystructuresandadiagnosticmarkerinependymoma‏ ‎‡A NHERF1/EBP50 is an organizer of polarity structures and a diagnostic marker in ependymoma‏ ‎‡9 1‏
919 ‎‡a nonbacterialthromboticendocarditisinbonemarrowtransplantpatients‏ ‎‡A Nonbacterial thrombotic endocarditis in bone marrow transplant patients.‏ ‎‡9 1‏
919 ‎‡a olfactorybulbalphasynucleinopathyhashighspecificityandsensitivityforlewybodydisorders‏ ‎‡A Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders‏ ‎‡9 1‏
919 ‎‡a pediatricoligodendrogliomasastudyofmolecularalterationson1pand19qusingfluorescenceinsituhybridization‏ ‎‡A Pediatric oligodendrogliomas: a study of molecular alterations on 1p and 19q using fluorescence in situ hybridization.‏ ‎‡9 1‏
919 ‎‡a percutaneoustranslumbarspinalcordcompressioninjuryinadogmodelthatusesangioplastyballoonsmrimagingandhistopathologicfindings‏ ‎‡A Percutaneous translumbar spinal cord compression injury in a dog model that uses angioplasty balloons: MR imaging and histopathologic findings.‏ ‎‡9 1‏
919 ‎‡a percutaneoustranslumbarspinalcordcompressioninjuryindogsfromanangioplastyballoonmrandhistopathologicchangeswithballoonsizesandcompressiontimes‏ ‎‡A Percutaneous translumbar spinal cord compression injury in dogs from an angioplasty balloon: MR and histopathologic changes with balloon sizes and compression times‏ ‎‡9 1‏
919 ‎‡a peripheralvh4+plasmablastsdemonstrateautoreactivebcellexpansiontowardbrainantigensinearlymultiplesclerosispatients‏ ‎‡A Peripheral VH4+ plasmablasts demonstrate autoreactive B cell expansion toward brain antigens in early multiple sclerosis patients‏ ‎‡9 1‏
919 ‎‡a phlpp2suppressesthenfκbpathwaybyinactivatingikkβkinase‏ ‎‡A PHLPP2 suppresses the NF-κB pathway by inactivating IKKβ kinase‏ ‎‡9 1‏
919 ‎‡a phosphorylationofthetubulinbindingproteinstathminbycdk5andmapkinasesinthebrain‏ ‎‡A Phosphorylation of the tubulin-binding protein, stathmin, by Cdk5 and MAP kinases in the brain.‏ ‎‡9 1‏
919 ‎‡a predictorsofcognitiveimpairmentinprimaryagerelatedtauopathyanautopsystudy‏ ‎‡A Predictors of cognitive impairment in primary age-related tauopathy: an autopsy study‏ ‎‡9 1‏
919 ‎‡a primaryagerelatedtauopathy‏ ‎‡A Primary age-related tauopathy‏ ‎‡9 1‏
919 ‎‡a primaryagerelatedtauopathypartacommonpathologyassociatedwithhumanaging‏ ‎‡A Primary age-related tauopathy (PART): a common pathology associated with human aging‏ ‎‡9 1‏
919 ‎‡a prognosticvalueofproliferationindexandexpressionofthernacomponentofhumantelomerase‏ ‎‡A Prognostic value of proliferation index and expression of the RNA component of human telomerase‏ ‎‡9 1‏
919 ‎‡a prognosticvalueofproliferationindexandexpressionofthernacomponentofhumantelomerasehtrinpapillarymeningiomas‏ ‎‡A Prognostic value of proliferation index and expression of the RNA component of human telomerase (hTR) in papillary meningiomas‏ ‎‡9 1‏
919 ‎‡a progressivesupranuclearpalsywithdementiacorticalpathology‏ ‎‡A Progressive supranuclear palsy with dementia: cortical pathology.‏ ‎‡9 1‏
919 ‎‡a proliferativeactivityincraniopharyngiomasclinicopathologicalcorrelationsinadultsandchildren‏ ‎‡A Proliferative activity in craniopharyngiomas: clinicopathological correlations in adults and children.‏ ‎‡9 1‏
919 ‎‡a proteinphosphatase2aassociateswithandregulatesatypicalpkcandtheepithelialtightjunctioncomplex‏ ‎‡A Protein phosphatase 2A associates with and regulates atypical PKC and the epithelial tight junction complex‏ ‎‡9 1‏
919 ‎‡a reducedsynapticstim2expressionandimpairedstoreoperatedcalciumentrycausedestabilizationofmaturespinesinmutantpresenilinmice‏ ‎‡A Reduced synaptic STIM2 expression and impaired store-operated calcium entry cause destabilization of mature spines in mutant presenilin mice‏ ‎‡9 1‏
919 ‎‡a regionalchangesofcorticalmeandiffusivitieswithagingaftercorrectionofpartialvolumeeffects‏ ‎‡A Regional changes of cortical mean diffusivities with aging after correction of partial volume effects‏ ‎‡9 1‏
919 ‎‡a replylatetotheparty‏ ‎‡A Reply: LATE to the PART-y‏ ‎‡9 1‏
919 ‎‡a responsetoparkinnenetalandjellinger‏ ‎‡A Response to Parkinnen et al. and Jellinger‏ ‎‡9 1‏
919 ‎‡a reversiblemiddlecerebralarteryembolizationindogswithoutintracranialsurgery‏ ‎‡A Reversible middle cerebral artery embolization in dogs without intracranial surgery.‏ ‎‡9 1‏
919 ‎‡a riskfactorsforearlierdementiaonsetinautopsyconfirmedalzheimersdiseasemixedalzheimerswithlewybodiesandpurelewybodydisease‏ ‎‡A Risk factors for earlier dementia onset in autopsy-confirmed Alzheimer's disease, mixed Alzheimer's with Lewy bodies, and pure Lewy body disease‏ ‎‡9 1‏
919 ‎‡a spinocerebellarataxiatype3acasereportandliteraturereview‏ ‎‡A Spinocerebellar Ataxia Type 3: A Case Report and Literature Review‏ ‎‡9 1‏
919 ‎‡a synapselossmaybeaminorcontributortodecreasedregionalcerebralbloodflowinalzheimerdisease‏ ‎‡A Synapse loss may be a minor contributor to decreased regional cerebral blood flow in Alzheimer disease.‏ ‎‡9 1‏
919 ‎‡a tardnabindingprotein43immunohistochemistryrevealsextensiveneuriticpathologyinftlduamidwestsouthwestconsortiumforftldstudy‏ ‎‡A TAR DNA-binding protein 43 immunohistochemistry reveals extensive neuritic pathology in FTLD-U: a midwest-southwest consortium for FTLD study‏ ‎‡9 1‏
919 ‎‡a tc99mhmpaobrainbloodflowimaginginthedementiaswithhistopathologiccorrelationin73patients‏ ‎‡A TC-99m HMPAO Brain Blood Flow Imaging in the Dementias with Histopathologic Correlation in 73 Patients‏ ‎‡9 1‏
919 ‎‡a tc99mhmpaospectinthedifferentialdiagnosisofthedementiaswithhistopathologicconfirmation‏ ‎‡A Tc-99m HMPAO SPECT in the differential diagnosis of the dementias with histopathologic confirmation.‏ ‎‡9 1‏
919 ‎‡a tdp43a315tmutationinfamilialmotorneurondisease‏ ‎‡A TDP-43 A315T mutation in familial motor neuron disease‏ ‎‡9 1‏
919 ‎‡a tdp43infamilialandsporadicfrontotemporallobardegenerationwithubiquitininclusions‏ ‎‡A TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions‏ ‎‡9 1‏
919 ‎‡a tdp43pathologyinprimaryprogressiveaphasiaandfrontotemporaldementiawithpathologicalzheimerdisease‏ ‎‡A TDP-43 pathology in primary progressive aphasia and frontotemporal dementia with pathologic Alzheimer disease‏ ‎‡9 1‏
919 ‎‡a proteinphosphatasepp2abαbindstothemicrotubuleassociatedproteinstauandmap2atamotifalsorecognizedbythekinasefynimplicationsfortauopathies‏ ‎‡A The protein phosphatase PP2A/Bα binds to the microtubule-associated proteins Tau and MAP2 at a motif also recognized by the kinase Fyn: implications for tauopathies.‏ ‎‡9 1‏
919 ‎‡a roleofcorticalconnectivityinalzheimersdiseasepathogenesisareviewandmodelsystem‏ ‎‡A The role of cortical connectivity in Alzheimer's disease pathogenesis: a review and model system.‏ ‎‡9 1‏
919 ‎‡a tmem106bprotectsc9orf72expansioncarriersagainstfrontotemporaldementia‏ ‎‡A TMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 CAOONL|ncf11159389‏
996 ‎‡2 NTA|274737353‏
996 ‎‡2 NTA|072808209‏
996 ‎‡2 SUDOC|150357192‏
996 ‎‡2 DE633|pe50052030‏
996 ‎‡2 ISNI|0000000054490229‏
996 ‎‡2 PTBNP|1223772‏
996 ‎‡2 LC|no2020149274‏
996 ‎‡2 LC|no2010180112‏
996 ‎‡2 LC|n 2014038752‏
996 ‎‡2 NKC|jo20211133310‏
996 ‎‡2 DNB|1270311492‏
996 ‎‡2 NUKAT|n 2018165047‏
996 ‎‡2 SUDOC|122817168‏
996 ‎‡2 J9U|987008914662205171‏
996 ‎‡2 ISNI|0000000038253418‏
996 ‎‡2 ISNI|0000000436075450‏
996 ‎‡2 LC|n 86130403‏
996 ‎‡2 J9U|987007281780305171‏
996 ‎‡2 LC|no2002083765‏
996 ‎‡2 LIH|LNB:DUCQ;=BJ‏
996 ‎‡2 BIBSYS|90609925‏
996 ‎‡2 NUKAT|n 2015148924‏
996 ‎‡2 RERO|A022780151‏
996 ‎‡2 NII|DA06916489‏
996 ‎‡2 LC|n 2022005027‏
996 ‎‡2 LC|no2014133152‏
996 ‎‡2 RERO|A003971350‏
996 ‎‡2 LC|n 88293891‏
996 ‎‡2 NLA|000035519871‏
996 ‎‡2 BIBSYS|7019562‏
996 ‎‡2 BIBSYS|90070243‏
996 ‎‡2 LC|no2012139346‏
996 ‎‡2 SUDOC|069454027‏
996 ‎‡2 BIBSYS|1523345893474‏
996 ‎‡2 CAOONL|ncf10494795‏
996 ‎‡2 LC|n 2004071223‏
996 ‎‡2 DNB|117334367‏
996 ‎‡2 ISNI|0000000074192528‏
996 ‎‡2 ISNI|0000000027675148‏
996 ‎‡2 NUKAT|n 2006114472‏
996 ‎‡2 LC|no 91011591‏
996 ‎‡2 LC|n 92054780‏
996 ‎‡2 LC|nr 93042027‏
996 ‎‡2 LC|no2013098935‏
996 ‎‡2 NII|DA00602397‏
996 ‎‡2 BAV|495_107903‏
996 ‎‡2 LC|no2005090348‏
996 ‎‡2 J9U|987007376421505171‏
996 ‎‡2 NTA|315487224‏
996 ‎‡2 ISNI|0000000123586073‏
996 ‎‡2 LC|no 00037806‏
996 ‎‡2 CAOONL|ncf10483820‏
996 ‎‡2 DNB|1233062212‏
996 ‎‡2 DNB|1260592197‏
996 ‎‡2 ISNI|0000000074537223‏
996 ‎‡2 ISNI|0000000041958208‏
996 ‎‡2 LC|no2005094313‏
996 ‎‡2 LC|no 99051885‏
996 ‎‡2 CAOONL|ncf11660799‏
996 ‎‡2 ISNI|0000000078010525‏
996 ‎‡2 SUDOC|119701111‏
996 ‎‡2 NII|DA03069513‏
996 ‎‡2 LC|n 2018183856‏
996 ‎‡2 SUDOC|103122575‏
996 ‎‡2 ISNI|0000000081945559‏
996 ‎‡2 W2Z|11053925‏
996 ‎‡2 SUDOC|066970598‏
996 ‎‡2 J9U|987007328181305171‏
996 ‎‡2 LC|no2007036887‏
996 ‎‡2 RERO|A012360753‏
996 ‎‡2 PTBNP|1390415‏
996 ‎‡2 J9U|987007381464505171‏
996 ‎‡2 LC|no2019117805‏
996 ‎‡2 BIBSYS|90299726‏
996 ‎‡2 PLWABN|9810594034605606‏
996 ‎‡2 DNB|130647993‏
996 ‎‡2 ISNI|0000000500988298‏
996 ‎‡2 SUDOC|233023526‏
996 ‎‡2 LC|no 97067500‏
996 ‎‡2 J9U|987007354428305171‏
996 ‎‡2 NTA|073650420‏
996 ‎‡2 CAOONL|ncf11560464‏
996 ‎‡2 LC|no2019183359‏
996 ‎‡2 NTA|181972069‏
996 ‎‡2 RERO|A006604249‏
996 ‎‡2 LC|n 2014187883‏
996 ‎‡2 LC|n 85011192‏
996 ‎‡2 BLBNB|000386257‏
996 ‎‡2 SUDOC|069003033‏
996 ‎‡2 LIH|LNB:V6_h_;=B_a_‏
996 ‎‡2 PLWABN|9810648523805606‏
996 ‎‡2 ISNI|0000000082005809‏
996 ‎‡2 NUKAT|n 2009075258‏
996 ‎‡2 J9U|987007387085605171‏
996 ‎‡2 LC|no2007085018‏
996 ‎‡2 RERO|A006442420‏
996 ‎‡2 N6I|vtls001094200‏
996 ‎‡2 LC|nb2015009098‏
996 ‎‡2 ISNI|0000000382331913‏
996 ‎‡2 RERO|A012434324‏
996 ‎‡2 NYNYRILM|200836‏
996 ‎‡2 LC|n 2014191057‏
996 ‎‡2 LC|no2008187163‏
996 ‎‡2 ISNI|0000000029774182‏
996 ‎‡2 ISNI|0000000396290243‏
996 ‎‡2 SUDOC|127678638‏
996 ‎‡2 NYNYRILM|270804‏
996 ‎‡2 ISNI|0000000104224878‏
996 ‎‡2 NLA|000035954845‏
996 ‎‡2 J9U|987007430268705171‏
996 ‎‡2 LC|no 94029947‏
996 ‎‡2 LC|n 78050538‏
996 ‎‡2 LC|no 92014431‏
996 ‎‡2 LC|no2015153480‏
996 ‎‡2 JPG|500125887‏
996 ‎‡2 J9U|987007280377105171‏
996 ‎‡2 DNB|11733409X‏
996 ‎‡2 NUKAT|n 2017075979‏
996 ‎‡2 LC|no2019178606‏
996 ‎‡2 B2Q|0000293652‏
996 ‎‡2 LC|nr2004002447‏
996 ‎‡2 ISNI|0000000047093348‏
996 ‎‡2 LC|n 85306893‏
996 ‎‡2 LC|n 2004060256‏
996 ‎‡2 LC|no2015007761‏
996 ‎‡2 LC|n 86047411‏
996 ‎‡2 SUDOC|199741778‏
996 ‎‡2 BIBSYS|90051759‏
996 ‎‡2 BIBSYS|90673029‏
996 ‎‡2 JPG|500105652‏
996 ‎‡2 BNF|13740897‏
996 ‎‡2 ISNI|0000000024813285‏
996 ‎‡2 DNB|1284343561‏
996 ‎‡2 BNF|12055498‏
996 ‎‡2 SUDOC|255482469‏
996 ‎‡2 LC|no2007079187‏
996 ‎‡2 LC|n 2011037140‏
996 ‎‡2 NLA|000035603897‏
996 ‎‡2 LC|n 88254911‏
996 ‎‡2 CAOONL|ncf11854980‏
996 ‎‡2 ISNI|0000000068507765‏
996 ‎‡2 LC|nb2010030073‏
996 ‎‡2 BNF|13476439‏
996 ‎‡2 LC|n 2004119933‏
996 ‎‡2 DNB|1029686955‏
996 ‎‡2 ISNI|0000000054595792‏
996 ‎‡2 LC|n 88108682‏
996 ‎‡2 LC|n 99285818‏
996 ‎‡2 RERO|A012529297‏
996 ‎‡2 NUKAT|n 2012069303‏
996 ‎‡2 N6I|vtls000019549‏
996 ‎‡2 DNB|120038167X‏
996 ‎‡2 ISNI|0000000044253342‏
996 ‎‡2 ISNI|0000000079846201‏
996 ‎‡2 DNB|135953537‏
996 ‎‡2 LC|n 2011042955‏
996 ‎‡2 ISNI|0000000402838384‏
996 ‎‡2 BIBSYS|2245‏
996 ‎‡2 JPG|500259358‏
996 ‎‡2 BIBSYS|90320635‏
996 ‎‡2 ISNI|000000044782092X‏
996 ‎‡2 JPG|500013595‏
996 ‎‡2 BIBSYS|90064867‏
996 ‎‡2 BIBSYS|9046961‏
996 ‎‡2 LC|n 80031509‏
996 ‎‡2 ISNI|0000000364775473‏
996 ‎‡2 ISNI|000000011932680X‏
996 ‎‡2 LC|n 2005071216‏
996 ‎‡2 DNB|135421136‏
996 ‎‡2 ISNI|0000000112644223‏
996 ‎‡2 ISNI|000000012278107X‏
996 ‎‡2 ISNI|0000000071148927‏
996 ‎‡2 BIBSYS|3062179‏
996 ‎‡2 ISNI|0000000063220503‏
996 ‎‡2 J9U|987007275529305171‏
996 ‎‡2 SUDOC|139614826‏
996 ‎‡2 ISNI|0000000029487319‏
996 ‎‡2 J9U|987007369059105171‏
996 ‎‡2 BNF|15154376‏
996 ‎‡2 ISNI|0000000496856005‏
996 ‎‡2 J9U|987007375194305171‏
996 ‎‡2 NII|DA13717981‏
996 ‎‡2 BIBSYS|90261917‏
996 ‎‡2 LC|no2005021998‏
996 ‎‡2 ISNI|000000011853800X‏
996 ‎‡2 BNF|15580145‏
996 ‎‡2 ISNI|0000000034512267‏
996 ‎‡2 ISNI|0000000112080413‏
996 ‎‡2 NLA|000035230780‏
996 ‎‡2 ISNI|0000000500588024‏
996 ‎‡2 DNB|129819182‏
996 ‎‡2 ISNI|0000000448856764‏
996 ‎‡2 LC|nr2001034711‏
996 ‎‡2 LC|n 2018034000‏
996 ‎‡2 NSK|000254968‏
996 ‎‡2 NKC|xx0274394‏
996 ‎‡2 LC|no2008056205‏
996 ‎‡2 SUDOC|085975095‏
996 ‎‡2 LC|nr 95037925‏
996 ‎‡2 ISNI|0000000021510588‏
996 ‎‡2 DNB|173865771‏
996 ‎‡2 CAOONL|ncf11367195‏
996 ‎‡2 J9U|987007449750705171‏
996 ‎‡2 LC|n 88160079‏
996 ‎‡2 LC|n 2014036456‏
996 ‎‡2 LC|nb2011006338‏
996 ‎‡2 ISNI|0000000010369929‏
996 ‎‡2 RERO|A003971561‏
996 ‎‡2 NSK|000797762‏
996 ‎‡2 BIBSYS|90521446‏
996 ‎‡2 CAOONL|ncf10103643‏
996 ‎‡2 J9U|987012438468405171‏
996 ‎‡2 LC|n 89651979‏
996 ‎‡2 PTBNP|1546715‏
996 ‎‡2 ISNI|000000010713072X‏
996 ‎‡2 LC|n 96112628‏
996 ‎‡2 LC|no2011191374‏
996 ‎‡2 CAOONL|ncf11277368‏
996 ‎‡2 J9U|987007272181305171‏
996 ‎‡2 CAOONL|ncf11298582‏
996 ‎‡2 N6I|vtls000082069‏
996 ‎‡2 LC|no2010050625‏
996 ‎‡2 J9U|987007343326805171‏
996 ‎‡2 LC|n 86010005‏
996 ‎‡2 RERO|A003198906‏
996 ‎‡2 LC|no2022082003‏
996 ‎‡2 LC|n 83169590‏
996 ‎‡2 DNB|117663581‏
996 ‎‡2 NII|DA03056544‏
996 ‎‡2 BNF|16159144‏
996 ‎‡2 DNB|1175120219‏
996 ‎‡2 SUDOC|067210171‏
996 ‎‡2 PTBNP|48159‏
996 ‎‡2 ISNI|0000000076035681‏
996 ‎‡2 ISNI|0000000082807078‏
996 ‎‡2 SUDOC|189551348‏
996 ‎‡2 SUDOC|108938913‏
996 ‎‡2 SUDOC|074246860‏
996 ‎‡2 LC|n 2014036938‏
996 ‎‡2 ISNI|0000000362573974‏
996 ‎‡2 ISNI|000000011625197X‏
996 ‎‡2 LC|n 88021865‏
996 ‎‡2 BIBSYS|97048064‏
996 ‎‡2 NUKAT|n 2008073642‏
996 ‎‡2 LC|nr 93010900‏
996 ‎‡2 NTA|106826115‏
996 ‎‡2 DNB|1057370118‏
996 ‎‡2 NKC|nlk20000091370‏
996 ‎‡2 LC|no 94017242‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏